A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 2,762 shares of ABT stock, worth $328,042. This represents 0.41% of its overall portfolio holdings.

Number of Shares
2,762
Previous 2,762 -0.0%
Holding current value
$328,042
Previous $300,000 11.0%
% of portfolio
0.41%
Previous 0.41%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$102.07 - $123.37 $135,753 - $164,082
-1,330 Reduced 32.5%
2,762 $300,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $466,569 - $568,951
4,092 New
4,092 $484,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.